| MicroRNA and alternative mRNA splicing events in cancer drug response/resistance: potent therapeutic targets R Marima, FZ Francies, R Hull, T Molefi, M Oyomno, R Khanyile, ... Biomedicines 9 (12), 1818, 2021 | 27 | 2021 |
| AI and precision oncology in clinical cancer genomics: From prevention to targeted cancer therapies-an outcomes based patient care Z Dlamini, A Skepu, N Kim, M Mkhabele, R Khanyile, T Molefi, S Mbatha, ... Informatics in Medicine Unlocked 31, 100965, 2022 | 25 | 2022 |
| Role of precision oncology in type II endometrial and prostate cancers in the African population: global cancer genomics disparities R Marima, R Hull, M Mbeje, T Molefi, K Mathabe, AM Elbagory, ... International Journal of Molecular Sciences 23 (2), 628, 2022 | 15 | 2022 |
| From incidence to intervention: a comprehensive look at breast cancer in South Africa Z Dlamini, T Molefi, R Khanyile, M Mkhabele, B Damane, A Kokoua, ... Oncology and Therapy 12 (1), 1-11, 2024 | 10 | 2024 |
| Society 5.0: Realizing next-generation healthcare Z Dlamini, TV Miya, R Hull, T Molefi, R Khanyile, JF de Vasconcellos Society 5.0 and Next Generation Healthcare: Patient-Focused and Technology …, 2023 | 10 | 2023 |
| Genomics and splicing events of type II endometrial cancers in the black population: racial disparity, socioeconomic and geographical differences FZ Francies, R Marima, R Hull, T Molefi, Z Dlamini American Journal of Cancer Research 10 (10), 3061, 2020 | 8 | 2020 |
| Overcoming the challenges of phytochemicals in triple negative breast cancer therapy: the path forward M Alaouna, C Penny, R Hull, T Molefi, N Chauke-Malinga, R Khanyile, ... Plants 12 (12), 2350, 2023 | 7 | 2023 |
| Viral encoded miRNAs in tumorigenesis: Theranostic opportunities in precision oncology R Hull, R Marima, M Alaouna, D Demetriou, RM Reis, T Molefi, Z Dlamini Microorganisms 10 (7), 1448, 2022 | 6 | 2022 |
| Use of artificial intelligence in implementing mainstream precision medicine to improve traditional symptom-driven practice of medicine: allowing early interventions and … T Luvhengo, T Molefi, D Demetriou, R Hull, Z Dlamini Artificial Intelligence and Precision Oncology: Bridging Cancer Research and …, 2023 | 5 | 2023 |
| Alternative splicing events and their clinical significance in colorectal cancer: targeted therapeutic opportunities MA Manabile, R Hull, R Khanyile, T Molefi, BP Damane, NP Mongan, ... Cancers 15 (15), 3999, 2023 | 4 | 2023 |
| Employing AI-Powered decision support systems in recommending the most effective therapeutic approaches for Individual Cancer patients: Maximising Therapeutic Efficacy T Molefi, R Marima, D Demetriou, A Basera, Z Dlamini Artificial Intelligence and Precision Oncology: bridging Cancer Research and …, 2023 | 3 | 2023 |
| Genomic Interplay between Neoneurogenesis and Neoangiogenesis in Carcinogenesis: Therapeutic Interventions Z Dlamini, R Khanyile, T Molefi, BP Damane, DO Bates, R Hull Cancers 15 (6), 1805, 2023 | 2 | 2023 |
| Exploring Water-Soluble South African Tulbaghia violacea Harv Extract as a Therapeutic Approach for Triple-Negative Breast Cancer Metastasis M Alaouna, R Hull, T Molefi, R Khanyile, L Mbodi, TE Luvhengo, ... Current Issues in Molecular Biology 46 (10), 10806-10828, 2024 | 1 | 2024 |
| Health informatics applications in healthcare and society 5.0 R Marima, N Mtshali, P Phillips, T Molefi, R Khanyile, Z Mbita, M Mbeje, ... Society 5.0 and Next Generation Healthcare: Patient-Focused and Technology …, 2023 | 1 | 2023 |
| The potential of the South African plant Tulbaghia Violacea Harv for the treatment of triple negative breast cancer M Alaouna, T Molefi, R Khanyile, N Chauke-Malinga, A Chatziioannou, ... Scientific Reports 15 (1), 5737, 2025 | | 2025 |
| From Genes to Clinical Practice: Exploring the Genomic Underpinnings of Endometrial Cancer T Molefi, L Mabonga, R Hull, M Sebitloane, Z Dlamini Cancers 17 (2), 320, 2025 | | 2025 |
| Overcoming chemotherapy resistance in colorectal cancer D Demetriou, T Molefi, A Chatziioannou, Z Dlamini Colorectal Cancer Treatment Resistance, 85-105, 2025 | | 2025 |
| Gut Microbiome and Cancer Treatment Response T Molefi, T Chipiti, B Mosoane, R Mehrotra, Z Dlamini Exploring the Gut Microbiome in Cancer, 26-39, 2024 | | 2024 |
| Conclusion: Navigating the Future of Prostate Cancer Care Z Dlamini, R Hull, R Khanyile, T Molefi, B Gaudji, A Kokoua Transforming Prostate Cancer Care: Advancing Cancer Treatment with Insights …, 2024 | | 2024 |
| Survivorship and Quality of Life: Addressing the Physical and Emotional Well-Being of Prostate Cancer Patients T Chipiti, T Molefi, D Demetriou, G Lolas, Z Dlamini Transforming Prostate Cancer Care: Advancing Cancer Treatment with Insights …, 2024 | | 2024 |